± HEALTH The significant advancements in applying artificial intelligence (AI) to healthcare decision-making, medical…− CLIMATE Abstract Deep learning workloads have experienced rapid growth which has resulted in higher energy consumptio…− EDUCATION Generative artificial intelligence (Gen AI) has taken the academic world by storm. This G.I.F.T.S. paper argu…± HEALTH Spontaneous intracerebral hemorrhage (ICH) is a highly lethal and disabling form of stroke, in which hematoma…− HEALTH Aim To explore the notion of post-humanism and the impact of artificial intelligence (AI) on society, nursing…± EDUCATION Aim To examine nursing academics' perceptions and experiences of artificial intelligence (AI) integration in…+ CRIME Riverbank erosion is a catastrophic geomorphological hazard that poses severe ecological and socio-economic c…+ HEALTH Immunotherapy resistance in lung adenocarcinoma (LUAD) remains a critical clinical challenge, and the mechani…
TruaceTracing the truth around AIMonday, August 17, 2026
Subscribe
Health·P Space·Evidence-backed problem·Published 2026-07-12

Blue Ortho 22 Chemin Du Vieux Chene Meylan France recalls an AI-enabled medical device

Abstract: Predict+ is a data-driven, clinical decision support tool that uses machine learning to provide predictions of individual patient outcomes after shoulder replacement surgery Recall reason: Predict+ is being recalled for lack of pre-market clearance/approval.

TRV-2026-0044Peer-reviewed ×2Permanent record — cite & verify
Blue Ortho 22 Chemin Du Vieux Chene Meylan France recalls an AI-enabled medical device

"Sarasota - Janet in Doctors Hospital" by roger4336 is licensed under CC BY-SA 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-sa/2.0/.

The quick read

On 2026-02-05, Blue Ortho initiated a recall of Predict+, an AI-enabled clinical decision support tool that uses machine learning to predict outcomes after shoulder replacement surgery, because the device lacked pre-market clearance/approval.

The case illustrates a concrete regulatory consequence for deploying an AI clinical tool without authorization, highlighting gaps in pre-market oversight for machine learning decision support. What is still unknown is the scale of deployment, any clinical impact, and the pathway to compliance.

Main points
  • Predict+ is described as a data-driven clinical decision support tool that uses machine learning for shoulder replacement outcomes.
  • The recall reason listed is lack of pre-market clearance/approval.
  • Manufacturer identified as Blue Ortho at 22 Chemin Du Vieux Chene Meylan France.
Problem

Predict+ was recalled because the AI-enabled clinical decision support tool for shoulder replacement outcomes lacked required pre-market clearance/approval.

The rundown

By 2026-02-05, npj Digital Medicine reported that Blue Ortho recalled Predict+, a data-driven clinical decision support tool that uses machine learning to predict individual patient outcomes after shoulder replacement surgery. The stated recall reason was lack of pre-market clearance/approval.

The recall matters because it shows regulatory enforcement catching an AI-enabled surgical planning tool deployed without required authorization, raising questions about how many patients were exposed and whether efficacy claims were validated. It remains unclear whether the recall involved safety issues, patient harm, or only procedural non-compliance.

Sources

Reader signal

How should this claim be treated?

The debate